Schedule 13D ownership disclosure

Edesa Biotech, Inc.

Security class unavailable · CUSIP: 27966L108

Event date: 2019-07-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,704,344
Percent of class
22.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001654954-19-009776
Form type
SC 13D
Filer
Edesa Biotech, Inc.
CIK
CIK 1540159
Filed
Aug 19, 2019
Reporting period
Jul 26, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub